Impact of β-Lactamase Inhibition on the Activity of Ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus

被引：36

作者：

Dubee, Vincent ^{[1
,2
,3
,4
]}

Soroka, Daria ^{[1
,2
,3
]}

Cortes, Melanie ^{[1
,2
,3
]}

Lefebvre, Anne-Laure ^{[1
,2
,3
]}

Gutmann, Laurent ^{[1
,2
,3
,5
]}

Hugonnet, Jean-Emmanuel ^{[1
,2
,3
]}

Arthur, Michel ^{[1
,2
,3
]}

Mainardi, Jean-Luc ^{[1
,2
,3
,5
]}

机构：

[1] INSERM, LRMA, Ctr Rech Cordeliers, Equipe 12,UMR S 1138, Paris, France

[2] Univ Paris 06, Sorbonne Univ, Ctr Rech Cordeliers, UMR S 1138, Paris, France

[3] Univ Paris 05, Ctr Rech Cordeliers, Sorbonne Paris Cite, UMR S 1138, Paris, France

[4] Hop St Antoine, AP HP, Serv Reanimat Med, F-75571 Paris, France

[5] Hop Europeen Georges Pompidou, AP HP, Paris, France

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2015年 / 59卷 / 05期

关键词：

MASSILIENSE; CEPHALOSPORIN; INFECTIONS; ACID;

D O I：

10.1128/AAC.05080-14

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The production of beta-lactamases BlaMab and BlaC contributes to beta-lactam resistance in Mycobacterium abscessus and Mycobacterium tuberculosis, respectively. Ceftaroline was efficiently hydrolyzed by these enzymes. Inhibition of M. tuberculosis BlaC by clavulanate decreased the ceftaroline MIC from >= 256 to 16 to 64 mu g/ml, but these values are clinically irrelevant. In contrast, the ceftaroline-avibactam combination should be evaluated against M. abscessus since it inhibited growth at lower and potentially achievable drug concentrations.

引用

页码：2938 / 2941

页数：4

共 50 条

[21] Omadacycline enhances the in vitro activity of clofazimine against Mycobacterium abscessus
Mudde, S. E.
Meliefste, H. M.
Ammerman, N. C.
DE Steenwinkel, J. E. M.
Bax, H. I.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2024, 28 (11) : 554 - 556
[22] In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex
Lavollay, M.
Dubee, V.
Heym, B.
Herrmann, J. -L.
Gaillard, J. -L.
Gutmann, L.
Arthur, M.
Mainardi, J. -L.
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (05) : O297 - O300
[23] Opisthotonos with preserved consciousness in a patient with coinfection by Mycobacterium tuberculosis and Mycobacterium abscessus
Shree, Ritu
Goel, Abeer
Modi, Manish
Goyal, Manoj
Sharma, Kusum
Lakhanpal, Vikas
Balaini, Neeraj
Mahesh, Karthik
Lal, Vivek
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 76 - 76
[24] Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus
Lindman, Marissa
Dick, Thomas
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)
[25] In vitro evaluation of the antibacterial activity of nemonoxacin against Mycobacterium abscessus
李冰
ChinaMedicalAbstracts(InternalMedicine), 2022, 39 (01) : 37 - 38
[26] Alternatives to Antibiotics against Mycobacterium abscessus
Broncano-Lavado, Antonio
Senhaji-Kacha, Abrar
Santamaria-Corral, Guillermo
Esteban, Jaime
Garcia-Quintanilla, Meritxell
ANTIBIOTICS-BASEL, 2022, 11 (10):
[27] In Vitro Activity of TP-271 against Mycobacterium abscessus, Mycobacterium fortuitum, and Nocardia Species
Cynamon, Michael
Jureller, Jeff
Desai, Balaji
Ramachandran, Krithika
Sklaney, Mary
Grossman, Trudy H.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) : 3986 - 3988
[28] In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense
Zhang, Zhijian
Lu, Jie
Liu, Min
Wang, Yufeng
Zhao, Yanlin
Pang, Yu
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (03) : 383 - 386
[29] Epetraborole Is Active against Mycobacterium abscessus
Ganapathy, Uday S.
Gengenbacher, Martin
Dick, Thomas
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
[30] Sudapyridine (WX-081) antibacterial activity against Mycobacterium avium, Mycobacterium abscessus, and Mycobacterium chelonae in vitro and in vivo
Zheng, Luyao
Wang, Hong
Qi, Xueting
Zhang, Weiyan
Wang, Bin
Fu, Lei
Chen, Xi
Chen, Xiaoyou
Lu, Yu
MSPHERE, 2024, 9 (02)

← 1 2 3 4 5 →